Page 1 of Clinical Trials for Drug adalimumab, 264 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
Last Updated: March 26, 2008
Condition(s): Arthritis; Psoriatic
2
Recruiting
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
Last Updated: May 7, 2012
Condition(s): Interstitial Cystitis
3
Recruiting
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
Last Updated: December 1, 2011
Condition(s): Arthritis, Rheumatoid
4
Terminated
Switching Anti-TNF-Alpha Agents in RA
Last Updated: May 8, 2011
Condition(s): Rheumatoid Arthritis
5
Active, not recruiting
A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission
Last Updated: April 24, 2012
Condition(s): Arthritis, Rheumatoid
6
Enrolling by invitation
Surveillance of Humira Injection in Korean Patients
Last Updated: April 30, 2012
Condition(s): Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Crohn's Disease; Psoriasis
7
Recruiting
ADALISKIAS: Adalimumab for Acute Disc Prolapse
Last Updated: January 16, 2012
Condition(s): Disc Prolapse; Pain
8
Recruiting
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
Last Updated: May 1, 2012
Condition(s): Rheumatoid Arthritis
9
Completed
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
Last Updated: August 9, 2011
Condition(s): Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
10
Completed
Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
Last Updated: October 19, 2007
Condition(s): Focal Glomerulosclerosis
11
Recruiting
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Last Updated: May 7, 2012
Condition(s): Psoriasis
12
Recruiting
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
Last Updated: May 23, 2011
Condition(s): Rheumatoid Arthritis
13
Completed
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
Last Updated: March 9, 2011
Condition(s): Hermanski-Pudlak Syndrome; Colitis; Cytokines; Lymphocytes; Drug Evaluation
14
Completed
A Post Marketing Observational Study (PMOS) of the Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biological Disease Modifying Anti-rheumatic Drugs (BDMARDs) Over 1 Year
Last Updated: September 22, 2011
Condition(s): Moderate to Severe Plaque Psoriasis
15
Recruiting
Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Last Updated: March 7, 2012
Condition(s): Ankylosing Spondylitis; Psoriatic Arthritis
16
Completed
Drug Use Investigation for Humira -All Patient Investigation for Rheumatoid Arthritis
Last Updated: July 21, 2011
Condition(s): Rheumatoid Arthritis
17
Active, not recruiting
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
Last Updated: May 7, 2012
Condition(s): Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
18
Recruiting
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Last Updated: April 9, 2012
Condition(s): Focal Segmental Glomerulosclerosis
19
Not yet recruiting
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
Last Updated: February 11, 2011
Condition(s): Rheumatoid Arthritis
20
Completed
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Last Updated: August 13, 2006
Condition(s): Crohn's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+adalimumab

Page 1 of Clinical Trials for Drug adalimumab, 264 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About